THE BUSINESS OF BIOTECH

46:08 24_01_BoB_1280x720_Ep250
The Implications Of China's Growing Biotech Industry With Allan Shaw

Business of Biotech MVP Allan Shaw is back to talk about the rise of China's biotech sector, and its evolution from fast follower to global innovation powerhouse.

ABOUT THE BUSINESS OF BIOTECH

Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.

FEATURED GUESTS

Allan Shaw
PLAY
Sara Bonstein
Insmed
PLAY
David Sans
PLAY
Nima Farzan
Latigo Biotherapeutics
PLAY
Kasper Roet
QurAlis
PLAY
Rick Modi
Affinia Therapeutics
PLAY
Brad Sitko
XOMA Royalty
PLAY
Owen Hughes
XOMA Royalty
PLAY
Thomas Chalberg
Genascence
PLAY
Ran Zheng
Landmark Bio
PLAY
Apple Spotify   YouTube

MEET YOUR HOST

Ben ComerBen Comer is chief editor of Life Science Leader magazine. He has covered the biopharmaceutical, medtech and medical device industries for 15 years as a reporter and editor, and worked as a senior manager in PwC’s Health Research Institute.

LINKEDIN

Interested in joining us on air? Contact us

bob-nl-tile-v2-350

THE BUSINESS OF BIOTECH PODCAST

46:08 24_01_BoB_1280x720_Ep250

The Implications Of China's Growing Biotech Industry With Allan Shaw

44:20 24_01_BoB_1280x720_Ep249

How To Be A CFO With Insmed's Sara Bonstein

46:43 24_01_BoB_1280x720_Ep248

Deal And Investment Trends With Investment Banker David Sans

34:44 24_01_BoB_1280x720_Ep247

Business of Biotech 2.0 with Ben Comer

43:32 24_01_BoB_1280x720_Ep246

BoB@JPM: Nima Farzan, Latigo Biotherapeutics

43:46 24_01_BoB_1280x720_Ep245

BoB@JPM: Kasper Roet, Ph.D., QurAlis

52:20 24_01_BoB_1280x720_Ep244

BoB@JPM: Rick Modi, Affinia Therapeutics

56:27 24_01_BoB_1280x720_Ep243

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

47:59 24_01_BoB_1280x720_Ep242

BoB@JPM: Tom Chalberg, Ph.D., Genascence

37:00 24_01_BoB_1280x720_Ep241

BoB@JPM: Ran Zheng, Landmark Bio

More Recent Episodes

FINANCE & CAPITAL MARKETS

35:37 24_01_BoB_1280x720_Ep3

Episode 3: The Biopharma Exit Strategy With Dr. Francois Nader

46:21 24_01_BoB_1280x720_Ep80

Venture Philanthropy For Type 1 Diabetes With T1D Fund's Katie Ellias

51:07 24_01_BoB_1280x720_Ep189

Managing Mergers With Sail's Guillaume Pfefer, Ph.D

52:50 24_01_BoB_1280x720_Ep232

A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.

34:06 24_01_BoB_1280x720_Ep22

Foundations Of Biopharma Finance With Smital Shah, MBA

48:47 24_01_BoB_1280x720_Ep159

Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard

49:47 24_01_BoB_1280x720_Ep183

Art Of The Pivot With Elevation Oncology's Joe Ferra

1:02:34 24_01_BoB_1280x720_Ep234

Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

30:38 24_01_BoB_1280x720_Ep55

Talking SPAC With Allan Shaw

54:05 24_01_BoB_1280x720_Ep218

Embracing Biotech Chaos With Memo's Erik van den Berg

More From Finance & Capital Markets

DISCOVERY/R&D

33:14 24_01_BoB_1280x720_Ep56

Intranasal Prophylactics For Flu & Coronavirus With Leyden Labs' Koenraad Wiedhaup

59:11 24_01_BoB_1280x720_Ep199

Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch

33:15 24_01_BoB_1280x720_Ep44

Drug Development: From Bench To Bedside With Allan Shaw

39:02 24_01_BoB_1280x720_Ep40

Supercharging An ADC Program With SOTIO CEO Dr. Radek Špíšek

38:55 24_01_BoB_1280x720_Ep91

Antibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.

47:06 24_01_BoB_1280x720_Ep93

Gynecological Cancer Therapies With Context Therapeutics' Martin Lehr

31:52 24_01_BoB_1280x720_Ep131

Computational Drug Discovery With Gain Therapeutics' Matthias Alder

59:16 24_01_BoB_1280x720_Ep168

Pragmatic Computational Biology with Andrew Satz

50:36 24_01_BoB_1280x720_Ep84

Plant-Based Biologics With iBio's Randy Maddux

56:38 24_01_BoB_1280x720_Ep203

Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.

More on Discovery

REGULATORY

1:02:40 24_01_BoB_1280x720_Ep224

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

41:26 BoB_Ep11

Taking ADCs Across The Finish Line

47:28 24_01_BoB_1280x720_Ep117

IND For TIL Therapy With Obsidian Therapeutics' Paul Wotton, Ph.D.

52:39 24_01_BoB_1280x720_Ep162

Facing NASH Therapeutic Skepticism With 89bio's Rohan Palekar

37:05 BoB_Ep30_2

Keeping Cell Therapy Clinicals On The Rails With Brian Culley

45:17 24_01_BoB_1280x720_Ep18

CMC Considerations For In-Human Studies With Drs. Edith Perez And Nathan Ihle

58:06 24_01_BoB_1280x720_Ep215

Steering Through Setbacks with AVEO Oncology's Michael Bailey

36:19 BoB_Ep35_2

Preparing For The Clinic With Amolyt Pharma's Dr. Thierry Abribat

37:39 BoB_Ep32_2

The FDA's Progressive Appeal ft. Allan Shaw

39:26 24_01_BoB_1280x720_Ep16

Data Quality & Master Files With Dr. Robert Hariri

More on Regulatory

MANUFACTURING

36:25 BoB_Ep66_2

CMC Developability Assessments For Rapid Ph.1 Entry With AltruBio's Gene Lee, Ph.D.

42:26 BoB_Ep41_2

Filling A Vaccine Void With Cue Biopharma's Dan Passeri, J.D.

56:17 24_01_BoB_1280x720_Ep99

Inflammation & Antibodies With Ampio Pharmaceutical's Mike Martino, CEO

55:06 BoB_Ep69_2

Foundations Of Flexible Manufacturing With Sarepta Therapeutics' Brian Winstead

38:27 BoB_Ep57_2

Peptides & Proteins: Resetting The Immune System With Revolo CEO Jonathan Rigby

44:09 BoB_Ep103_2

Antibody-Cytokine Combinations With Philogen's Dr. Dario Neri

57:35 24_01_BoB_1280x720_Ep202

The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch

1:00:24 24_01_BoB_1280x720_Ep134

Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.

57:09 BoB_Ep113_2

A Multiple Target Approach To Universal Influenza Vaccine Development

35:43 BoB_1280x720_Ep9

Solving The COVID-19 Workforce Crisis

More on Manufacturing